These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
17 results:

  • 1. Tiam1 methylation by NSD2 promotes rac1 signaling activation and colon cancer metastasis.
    Song D; Hu F; Huang C; Lan J; She X; Zhao C; Wu H; Liu A; Wu Q; Chen Y; Luo X; Feng Y; Yang X; Xu C; Hu J; Wang G
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2305684120. PubMed ID: 38113258
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DOCK4 is a Novel Prognostic Biomarker and Correlated with Immune Infiltrates in Colon Adenocarcinoma.
    Xie X; Lu Y; Wang B; Yin X; Chen J
    Comb Chem High Throughput Screen; 2024; 27(8):1119-1130. PubMed ID: 37702239
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circular RNA circ_0058123 Targets the miR-939-5p/rac1 Pathway to Promote the Development of colorectal cancer.
    Gao J; Chen J; Huang X; Zheng Y; Hu K
    Biochem Genet; 2024 Jun; 62(3):1485-1501. PubMed ID: 37642813
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ARHGAP17 enhances 5-Fluorouracil-induced apoptosis in colon cancer cells by suppressing rac1.
    Pan SL; Deng YY; Fu J; Zhang YH; Zhang ZJ; Qin XJ
    Neoplasma; 2022 May; 69(3):640-647. PubMed ID: 35293764
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel rapid immunohistochemistry using an alternating current electric field identifies Rac and Cdc42 activation in human colon cancer FFPE tissues.
    Tsuda M; Horio R; Wang L; Takenami T; Moriya J; Suzuka J; Sugino H; Tanei Z; Tanino M; Tanaka S
    Sci Rep; 2022 Feb; 12(1):1733. PubMed ID: 35110666
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
    Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
    Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through rac1 signaling activation.
    Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
    J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. rac1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3.
    Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. RCC2 is a novel p53 target in suppressing metastasis.
    Song C; Liang L; Jin Y; Li Y; Liu Y; Guo L; Wu C; Yun CH; Yin Y
    Oncogene; 2018 Jan; 37(1):8-17. PubMed ID: 28869598
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rab11 collaborates E-cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma.
    Chung YC; Wei WC; Hung CN; Kuo JF; Hsu CP; Chang KJ; Chao WT
    Eur J Clin Invest; 2016 Dec; 46(12):1002-1011. PubMed ID: 27696383
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating rac1.
    Rao J; Zhou ZH; Yang J; Shi Y; Xu SL; Wang B; Ping YF; Chen L; Cui YH; Zhang X; Wu F; Bian XW
    Cancer Lett; 2015 Mar; 358(1):76-84. PubMed ID: 25529012
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
    Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
    Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. rac1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy.
    Alonso-Espinaco V; Cuatrecasas M; Alonso V; Escudero P; Marmol M; Horndler C; Ortego J; Gallego R; Codony-Servat J; Garcia-Albeniz X; Jares P; Castells A; Lozano JJ; Rosell R; Maurel J
    Eur J Cancer; 2014 Jul; 50(11):1973-81. PubMed ID: 24833563
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. rac1b overexpression in papillary thyroid carcinoma: a role to unravel.
    Silva AL; Carmo F; Bugalho MJ
    Eur J Endocrinol; 2013 Jun; 168(6):795-804. PubMed ID: 23482591
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
    Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
    Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rac regulates the interaction of fascin with protein kinase C in cell migration.
    Parsons M; Adams JC
    J Cell Sci; 2008 Sep; 121(Pt 17):2805-13. PubMed ID: 18716283
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.